A Three-year Follow-up of Intravitreal Triamcinolone Acetonide Injection and Macular Laser Photocoagulation for Diffuse Diabetic Macular Edema

다국어 초록 (Multilingual Abstract)

Purpose: To report the three-year outcomes of macular laser photocoagulation following intravitreal injection of triamcinolone acetonide (IVTA) for diffuse diabetic macular edema (DME).
Methods: A prospective, randomized controlled study was completed. Eighty-six eyes of 74 patients with diffuse DME were randomized into two groups. Eyes assigned to the combination group (n = 48) were subjected to macular laser photocoagulation three weeks after IVTA. Eyes in the IVTA group (n = 38) underwent IVTA alone. Central macular thickness was measured by optical coherence tomography, and the number of additional treatments and mean time to recurrence were assessed.
Results: Thirty-seven eyes in the combination group and 26 eyes in the IVTA group completed the three-year follow-up. Recurrence of DME after initial treatment was not observed for nine of the 37 (24.3%) eyes in the combination group or for one of the 26 (3.9%) eyes in the IVTA group (p = 0.028). DME was absent for 19.9 months after treatment in the combination group compared to 10.3 months in the IVTA group (p = 0.027). The mean number of additional treatments was 0.92 in the combination group and 1.88 in the IVTA group (p = 0.001).
Conclusions: Results in the subset of subjects who completed the three-year follow-up demonstrated that laser photocoagulation following IVTA is more effective than IVTA monotherapy for diffuse DME. Combination therapy required fewer additional treatments and resulted in a lower recurrence rate than IVTA monotherapy.

참고문헌 (Reference)

1 Kang SW, "Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema" 144 : 878-885, 2007

2 Gillies MC, "Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial" 38 : 605-612, 2010

3 Diabetic Retinopathy Clinical Research Network (DRCR.net), "Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema" 127 : 245-251, 2009

4 Querques G, "Short-term fluctuation of diabetic macular edema after intravitreal ranibizumab injection" 29 : 1274-1281, 2009

5 Von Hanno T, "Retinal artery occlusion following intravitreal anti-VEGF therapy" 88 : 263-266, 2010

6 Diabetic Retinopathy Clinical Research Network, "Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema" 117 : 1064-1077, 2010

7 Arevalo JF, "Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American Collaborative Retina Study Group at 24 months" 116 : 1488-1497, 2009

8 "Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group" 103 : 1796-1806, 1985

9 Lee CM, "Modified grid laser photocoagulation for diffuse diabetic macular edema: long-term visual results" 98 : 1594-1602, 1991

10 Kang SW, "Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema" 124 : 653-658, 2006

11 Gillies MC, "Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial" 118 : 866-872, 2011

12 Lam DS, "Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes" 114 : 2162-2167, 2007

13 Ciardella AP, "Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study" 88 : 1131-1136, 2004

14 Papadopoulou DN, "Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration" 116 : 1755-1761, 2009

15 Jonas JB, "Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema" 132 : 425-427, 2001

16 Nagasawa T, "Efficacy of intravitreal bevacizumab (Avastin) for short-term treatment of diabetic macular edema" 56 : 111-115, 2009

17 Jonas JB, "Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema" 138 : 158-160, 2004

18 Bresnick GH, "Diabetic maculopathy: a critical review highlighting diffuse macular edema" 90 : 1301-1317, 1983

19 Estabrook EJ, "Can optical coherence tomography predict the outcome of laser photocoagulation for diabetic macular edema?" 38 : 478-483, 2007